These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 912585)

  • 1. Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Calcif Tissue Res; 1977 May; 22 Suppl():55-62. PubMed ID: 912585
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D resistant hypophosphataemic osteomalacia: treatment with 1alpha-hydroxyvitamin D3.
    Peacock M; Heyburn PJ; Aaron JE
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():231s-237s. PubMed ID: 203418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia.
    Peacock M; Aaron JE; Heyburn PJ; Nordin BE
    Adv Exp Med Biol; 1977; 81():431-40. PubMed ID: 899935
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
    Roof BS; Piel CF; Gordan GS
    Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
    [No Abstract]   [Full Text] [Related]  

  • 6. 1alpha-hydroxyvitamin D3 in the treatment of nutritional and metabolic rickets and osteomalacia.
    Gertner JM; Brenton DB; Edwards RH
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():239s-244s. PubMed ID: 203419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum parathyroid hormone concentrations in hypophosphataemic vitamin D resistant rickets.
    Fanconi A; Fischer JA; Prader A
    Helv Paediatr Acta; 1974 Aug; 29(3):187-94. PubMed ID: 4369169
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of adult onset hypophosphatemic vitamin D resistant osteomalacia].
    Katagiri T; Suzuki T; Akiyama Y; Ishibashi T; Hara K; Oka H; Imai T; Kobayashi K; Kitagawa H; Ohno S
    Ryumachi; 1992 Oct; 32(5):461-7; discussion 466-7. PubMed ID: 1440082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of hyperparathyroidism in children with X-linked hypophosphatemia under treatment with vitamin D and phsophate.
    Krohn HP; Offermann G; Brandis M; Brodehl J; Hanke K; Offner G
    Adv Exp Med Biol; 1977; 81():345-51. PubMed ID: 899930
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.
    Peacock M; Aaron JE; Walker GS; Davison AM
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():73s-81s. PubMed ID: 606428
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
    Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
    Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to heal D-deficiency rickets and suppress secondary hyperparathyroidism with conventional doses of 1,25-dihydroxy vitamin D3.
    Cundy T; Kanis JA; Heynen G; Earnshaw M; Clemens TL; O'Riordan JL; Merrett AL; Compston JE
    Br Med J (Clin Res Ed); 1982 Mar; 284(6319):883-5. PubMed ID: 6279228
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term therapy of viramin D-resistant richets with 25-hydroxycholecalciferol.
    Puschett JB; Genel M; Rastegar A; Anast C; DeLuca HF; Friedman A
    Clin Pharmacol Ther; 1975 Feb; 17(2):202-11. PubMed ID: 164313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum parathyroid hormone in hypophosphatemic vitamin D-resistant rickets.
    Lewy JE; Cabana EC; Repetto HA; Canterbury JM; Reiss E
    J Pediatr; 1972 Aug; 81(2):294-300. PubMed ID: 4339535
    [No Abstract]   [Full Text] [Related]  

  • 16. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
    Fujita T; Nomura M; Okajima S; Furuya H
    J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D therapy: problems and prospects.
    Drug Ther Bull; 1975 Apr; 13(8):29-31. PubMed ID: 165927
    [No Abstract]   [Full Text] [Related]  

  • 19. [A sporadic case of vitamin D-resistant rickets in an adult].
    Chiesa A; Barbera G; Scassa E
    Minerva Med; 1983 Feb; 74(6):255-60. PubMed ID: 6298662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypophosphataemic osteomalacia in adults.
    Lancet; 1971 Jun; 1(7713):1343. PubMed ID: 4103760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.